pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Podcast examines Merck and Moderna’s mRNA cancer vaccine data presented at ESMO

Oct 30, 2026·read at STAT ↗Neutral

The latest episode of STAT’s biotech podcast "The Readout LOUD" focused on the mRNA cancer vaccine being co‑developed by Merck and Moderna, using data shown at the European Society for Medical Oncology (ESMO) annual meeting.

Hosts Elaine Chen, Adam Feuerstein and Allison DeAngelis highlighted how the presented data were received by oncologists and discussed the scientific rationale behind the vaccine’s approach.

The discussion also turned to broader trends in oncology, including upcoming advances and the potential impact of mRNA technology on future cancer therapies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Assessing Merck and Moderna’s mRNA cancer vaccine”

read at STAT ↗
551 words · retrieved 23m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.5AMGENROCHE
drugs
Obesity2
topics
Oncology15Vaccine5mRNA Therapeutic5Obesity2NSCLCPulmonologyVaccines

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech
  • 1d agoLENZ cuts 75% of staff as third quarter earnings disappointBioSpace
  • Jul 23FDA panel confronting peptide controversySTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 3d agoOpinion: Cancer vaccines are finally here. How do we get them to patients?STAT